Advertisement
GE Healthcare
GE Healthcare

The Scientist

» drug development, evolution and immunology

Most Recent

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: Four-legged Snake Fossil Found

Four-legged Snake Fossil Found

By | July 27, 2015

Researchers discover an unprecedented paleontological relic that may just rewrite the book on snake evolution.

1 Comment

image: Warming Climate Hurt Megafauna?

Warming Climate Hurt Megafauna?

By | July 27, 2015

The massive mammals that roamed Earth some 30,000 years ago may have gone extinct as a result of global warming, according to an ancient-DNA study.

1 Comment

image: NK Cell Diversity and Viral Risk

NK Cell Diversity and Viral Risk

By | July 22, 2015

A small study links the diversity of a person’s natural killer cell repertoire to risk of HIV infection following exposure to the virus.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: “Feathered Poodle From Hell” Dino Found

“Feathered Poodle From Hell” Dino Found

By | July 20, 2015

A newly discovered relative of Velociraptor had abundant plumage and birdlike wings.  

0 Comments

image: Novel Hantavirus Infection Method

Novel Hantavirus Infection Method

By | July 3, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: MERS Help on the Horizon?

MERS Help on the Horizon?

By | July 1, 2015

New research finds that a treatment for Middle East respiratory syndrome can prevent and treat the disease in mice, while an experimental vaccine moves into human testing.

0 Comments

image: Brrrr-ying the Results

Brrrr-ying the Results

By | July 1, 2015

Holding laboratory mice at temperatures lower than those the animals prefer could be altering their physiology and skewing experimental results.

1 Comment

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Antibiotic Resistance Can Boost Bacterial Fitness
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
NeuroScientistNews
NeuroScientistNews
Advertisement
The Scientist